<?xml version='1.0' encoding='utf-8'?>
<document id="10064572"><sentence text="Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver."><entity charOffset="51-60" id="DDI-PubMed.10064572.s1.e0" text="midazolam" /><entity charOffset="64-76" id="DDI-PubMed.10064572.s1.e1" text="itraconazole" /><entity charOffset="81-93" id="DDI-PubMed.10064572.s1.e2" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.10064572.s1.e0" e2="DDI-PubMed.10064572.s1.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s1.e0" e2="DDI-PubMed.10064572.s1.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s1.e0" e2="DDI-PubMed.10064572.s1.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s1.e1" e2="DDI-PubMed.10064572.s1.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s1.e1" e2="DDI-PubMed.10064572.s1.e2" /></sentence><sentence text="To evaluate the extent of drug-drug interaction concerning metabolic inhibition in the liver quantitatively, we tried to predict the plasma concentration increasing ratio of midazolam (MDZ) by itraconazole (ITZ) or ketoconazole (KTZ) in rats"><entity charOffset="174-183" id="DDI-PubMed.10064572.s2.e0" text="midazolam" /><entity charOffset="185-188" id="DDI-PubMed.10064572.s2.e1" text="MDZ" /><entity charOffset="193-205" id="DDI-PubMed.10064572.s2.e2" text="itraconazole" /><entity charOffset="207-210" id="DDI-PubMed.10064572.s2.e3" text="ITZ" /><entity charOffset="215-227" id="DDI-PubMed.10064572.s2.e4" text="ketoconazole" /><entity charOffset="229-232" id="DDI-PubMed.10064572.s2.e5" text="KTZ" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e0" e2="DDI-PubMed.10064572.s2.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e0" e2="DDI-PubMed.10064572.s2.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e0" e2="DDI-PubMed.10064572.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e0" e2="DDI-PubMed.10064572.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e0" e2="DDI-PubMed.10064572.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e0" e2="DDI-PubMed.10064572.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e1" e2="DDI-PubMed.10064572.s2.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e1" e2="DDI-PubMed.10064572.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e1" e2="DDI-PubMed.10064572.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e1" e2="DDI-PubMed.10064572.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e1" e2="DDI-PubMed.10064572.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e2" e2="DDI-PubMed.10064572.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e2" e2="DDI-PubMed.10064572.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e2" e2="DDI-PubMed.10064572.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e2" e2="DDI-PubMed.10064572.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e3" e2="DDI-PubMed.10064572.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e3" e2="DDI-PubMed.10064572.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e3" e2="DDI-PubMed.10064572.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e4" e2="DDI-PubMed.10064572.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s2.e4" e2="DDI-PubMed.10064572.s2.e5" /></sentence><sentence text=" MDZ was administered at a dose of 10 mg/kg through the portal vein at 60 min after bolus administration of 20 mg/kg ITZ or during 0"><entity charOffset="1-3" id="DDI-PubMed.10064572.s3.e0" text="MDZ" /><entity charOffset="117-119" id="DDI-PubMed.10064572.s3.e1" text="ITZ" /><pair ddi="false" e1="DDI-PubMed.10064572.s3.e0" e2="DDI-PubMed.10064572.s3.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s3.e0" e2="DDI-PubMed.10064572.s3.e1" /></sentence><sentence text="33 mg/h/body of KTZ infusion"><entity charOffset="16-18" id="DDI-PubMed.10064572.s4.e0" text="KTZ" /></sentence><sentence text=" The ratio values in the area under the plasma concentration curve of MDZ in the presence of ITZ and KTZ was 2"><entity charOffset="70-72" id="DDI-PubMed.10064572.s5.e0" text="MDZ" /><entity charOffset="93-95" id="DDI-PubMed.10064572.s5.e1" text="ITZ" /><entity charOffset="101-103" id="DDI-PubMed.10064572.s5.e2" text="KTZ" /><pair ddi="false" e1="DDI-PubMed.10064572.s5.e0" e2="DDI-PubMed.10064572.s5.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s5.e0" e2="DDI-PubMed.10064572.s5.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s5.e0" e2="DDI-PubMed.10064572.s5.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s5.e1" e2="DDI-PubMed.10064572.s5.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s5.e1" e2="DDI-PubMed.10064572.s5.e2" /></sentence><sentence text="14 and 1" /><sentence text="67, respectively" /><sentence text=" The liver-unbound concentration to plasma-unbound concentration ratios of ITZ and KTZ were 11 approximately 14 and 1"><entity charOffset="75-77" id="DDI-PubMed.10064572.s8.e0" text="ITZ" /><entity charOffset="83-85" id="DDI-PubMed.10064572.s8.e1" text="KTZ" /><pair ddi="false" e1="DDI-PubMed.10064572.s8.e0" e2="DDI-PubMed.10064572.s8.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s8.e0" e2="DDI-PubMed.10064572.s8.e1" /></sentence><sentence text="3, respectively, suggesting a concentrative uptake of both drugs into the liver" /><sentence text=" ITZ and KTZ competitively inhibited the oxidative metabolism of MDZ in rat liver microsomes, and Ki values of ITZ and KTZ were 0"><entity charOffset="65-67" id="DDI-PubMed.10064572.s10.e0" text="MDZ" /><entity charOffset="1-3" id="DDI-PubMed.10064572.s10.e1" text="ITZ" /><entity charOffset="111-113" id="DDI-PubMed.10064572.s10.e2" text="ITZ" /><entity charOffset="9-11" id="DDI-PubMed.10064572.s10.e3" text="KTZ" /><entity charOffset="119-121" id="DDI-PubMed.10064572.s10.e4" text="KTZ" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e1" e2="DDI-PubMed.10064572.s10.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e1" e2="DDI-PubMed.10064572.s10.e3" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e1" e2="DDI-PubMed.10064572.s10.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e1" e2="DDI-PubMed.10064572.s10.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e1" e2="DDI-PubMed.10064572.s10.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e3" e2="DDI-PubMed.10064572.s10.e3" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e3" e2="DDI-PubMed.10064572.s10.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e3" e2="DDI-PubMed.10064572.s10.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e3" e2="DDI-PubMed.10064572.s10.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e0" e2="DDI-PubMed.10064572.s10.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e0" e2="DDI-PubMed.10064572.s10.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e0" e2="DDI-PubMed.10064572.s10.e4" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e2" e2="DDI-PubMed.10064572.s10.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s10.e2" e2="DDI-PubMed.10064572.s10.e4" /></sentence><sentence text="23 microM and 0" /><sentence text="16 microM, respectively" /><sentence text=" We predicted the ratio values of MDZ in the presence of ITZ and KTZ, using Ki values and unbound concentrations of both drugs in the plasma or liver"><entity charOffset="34-36" id="DDI-PubMed.10064572.s13.e0" text="MDZ" /><entity charOffset="57-59" id="DDI-PubMed.10064572.s13.e1" text="ITZ" /><entity charOffset="65-67" id="DDI-PubMed.10064572.s13.e2" text="KTZ" /><pair ddi="false" e1="DDI-PubMed.10064572.s13.e0" e2="DDI-PubMed.10064572.s13.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s13.e0" e2="DDI-PubMed.10064572.s13.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s13.e0" e2="DDI-PubMed.10064572.s13.e2" /><pair ddi="false" e1="DDI-PubMed.10064572.s13.e1" e2="DDI-PubMed.10064572.s13.e1" /><pair ddi="false" e1="DDI-PubMed.10064572.s13.e1" e2="DDI-PubMed.10064572.s13.e2" /></sentence><sentence text=" The predicted ratio values in the presence of ITZ or KTZ calculated by using unbound concentration in the plasma were 1"><entity charOffset="47-49" id="DDI-PubMed.10064572.s14.e0" text="ITZ" /><entity charOffset="54-56" id="DDI-PubMed.10064572.s14.e1" text="KTZ" /><pair ddi="false" e1="DDI-PubMed.10064572.s14.e0" e2="DDI-PubMed.10064572.s14.e0" /><pair ddi="false" e1="DDI-PubMed.10064572.s14.e0" e2="DDI-PubMed.10064572.s14.e1" /></sentence><sentence text="03 approximately 1" /><sentence text="05 and 1" /><sentence text="39, whereas those calculated using unbound concentration in the liver were 1" /><sentence text="73 approximately 1" /><sentence text="97 and 1" /><sentence text="51, respectively, which were very close to the observed ratio values" /><sentence text=" These findings indicated the necessity to consider the concentrative uptake of inhibitors into the liver for the quantitative prediction of the drug-drug interactions concerning metabolic inhibition in the liver" /><sentence text="" /></document>